Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2017 Dec 9;100(4):882–890. doi: 10.1016/j.ijrobp.2017.11.047

Table 5.

Decisional regret and EQ-5D-3L health utilities by treatment group

Surgery regret* (n = 463)
Radiation therapy regret, (n = 340)
EQ-5D-3L§ (n = 466)
n Mean (95% CI) P value n Mean (95% CI) P value n Mean (95% CI) P value
Lump + WBI 105 19.4 (9.8–29.0) Referent 103 28.5 (18.3–38.8) Referent 106 0.86 (0.81–0.90) Referent
Lump + Brachy 101 17.7 (8.5–26.8) .52 99 27.2 (17.0–37.4) .63 100 0.88 (0.84–0.92) .23
Lump alone 74 13.8 (3.4–24.2) .09 34 24.6 (14.1–35.0) .28 72 0.85 (0.79–0.90) .73
Mast alone 83 20.1 (10.8–29.4) .81 86 0.79 (0.73–0.86) .15
Mast + RT 100 22.0 (12.9–31.2) .28 104 33.4 (23.6–43.2) .10 102 0.78 (0.73–0.82)   .004

Abbreviations: CI = confidence interval; Lump alone = lumpectomy plus endocrine therapy alone; Lump + Brachy = lumpectomy plus brachytherapy; Lump + WBI = lumpectomy plus whole-breast irradiation; Mast alone = mastectomy alone; Mast + RT = mastectomy plus radiation therapy.

*

The model for surgery regret was adjusted for race, Charlson Comorbidity Index, patient-reported education, and income.

The model for radiation therapy regret was adjusted for race, Charlson Comorbidity Index, baseline body mass index, and region.

For the Lump alone group, the outcome was decisional regret regarding skipping radiation therapy.

§

The model for EQ-5D-3L was adjusted for Charlson Comorbidity Index, chemotherapy, and patient-reported income.